Cargando…
Downregulation of HNRNPM inhibits cell proliferation and migration of hepatocellular carcinoma through MAPK/AKT signaling pathway
BACKGROUND: HNRNPM is reported to be involved in multiple malignancies, while the prognostic and biological role of HNRNPM in hepatocellular carcinoma remains still unknown. METHODS: Public databases and tissue microarrays were employed to identify the expression pattern and prognostic value of HNRN...
Autores principales: | Qiao, Lu, Xie, Ning, Li, Yan, Bai, Yuru, Liu, Na, Wang, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372219/ https://www.ncbi.nlm.nih.gov/pubmed/35966311 http://dx.doi.org/10.21037/tcr-21-2484 |
Ejemplares similares
-
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2022) -
hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells
por: Passacantilli, Ilaria, et al.
Publicado: (2017) -
Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways
por: Kim, Heesue, et al.
Publicado: (2011) -
Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways
por: Luo, Yun, et al.
Publicado: (2016) -
Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion
por: Chen, Jintu, et al.
Publicado: (2021)